Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH) 

Enterprise Value to FCFF (EV/FCFF)

Microsoft Excel

Free Cash Flow to The Firm (FCFF)

UnitedHealth Group Inc., FCFF calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net earnings attributable to UnitedHealth Group common shareholders 12,056 14,405 22,381 20,120 17,285
Earnings attributable to noncontrolling interests 751 837 763 519 447
Net noncash charges 4,608 9,770 4,281 3,321 3,089
Net change in other operating items, net of effects from acquisitions and dispositions 2,282 (808) 1,643 2,246 1,522
Cash flows from operating activities 19,697 24,204 29,068 26,206 22,343
Cash paid for interest, net of tax1 3,510 2,728 2,413 1,523 1,314
Purchases of property, equipment and capitalized software (3,622) (3,499) (3,386) (2,802) (2,454)
Free cash flow to the firm (FCFF) 19,585 23,433 28,095 24,927 21,203

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


Over the five-year period examined, both cash flows from operating activities and free cash flow to the firm (FCFF) demonstrate a generally positive trend initially, followed by a decline. Cash flows from operating activities and FCFF both increased from 2021 to 2023, but then decreased in both 2024 and 2025.

Cash Flows from Operating Activities
Cash flows from operating activities increased from US$22,343 million in 2021 to US$29,068 million in 2023, representing a substantial increase over the period. However, a subsequent decrease is observed, with values falling to US$24,204 million in 2024 and further to US$19,697 million in 2025. This indicates a weakening in the cash generating ability of core business operations in the latter two years.
Free Cash Flow to the Firm (FCFF)
FCFF mirrored the trend in operating cash flows, rising from US$21,203 million in 2021 to US$28,095 million in 2023. Similar to operating cash flows, FCFF experienced a decline in the final two years, decreasing to US$23,433 million in 2024 and US$19,585 million in 2025. The decrease in FCFF suggests a reduction in the cash available to all investors, including debt and equity holders, after covering operating expenses and necessary capital expenditures.

The consistency of the trends between operating cash flows and FCFF suggests that changes in operating performance are the primary driver of fluctuations in free cash flow. The declines observed in both metrics during 2024 and 2025 warrant further investigation to determine the underlying causes, such as increased costs, decreased revenues, or changes in working capital requirements.

AI Ask an analyst for more


Interest Paid, Net of Tax

UnitedHealth Group Inc., interest paid, net of tax calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Effective Income Tax Rate (EITR)
EITR1 12.90% 24.10% 20.50% 21.70% 20.50%
Interest Paid, Net of Tax
Cash paid for interest, before tax 4,030 3,594 3,035 1,945 1,653
Less: Cash paid for interest, tax2 520 866 622 422 339
Cash paid for interest, net of tax 3,510 2,728 2,413 1,523 1,314

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 See details »

2 2025 Calculation
Cash paid for interest, tax = Cash paid for interest × EITR
= 4,030 × 12.90% = 520


A consistent increase in cash paid for interest, net of tax, is observed over the five-year period. Simultaneously, the effective income tax rate exhibits fluctuations. These trends are detailed below.

Cash Paid for Interest, Net of Tax
Cash paid for interest, net of tax, increased steadily from US$1,314 million in 2021 to US$3,510 million in 2025. This represents a cumulative increase of approximately 167% over the period. The year-over-year increases were US$209 million (2021-2022), US$890 million (2022-2023), US$315 million (2023-2024), and US$782 million (2024-2025). The largest single-year increase occurred between 2022 and 2023.
Effective Income Tax Rate
The effective income tax rate experienced variability throughout the period. It rose from 20.50% in 2021 to 21.70% in 2022, then returned to 20.50% in 2023. A notable increase to 24.10% occurred in 2024, followed by a substantial decrease to 12.90% in 2025. This suggests potential changes in the composition of taxable income or applicable tax laws during these years.
Relationship between Interest Paid and Tax Rate
While cash paid for interest, net of tax, consistently increased, the effective income tax rate did not demonstrate a corresponding trend. The decrease in the effective income tax rate in 2025, despite the highest level of interest paid, suggests that factors beyond interest expense significantly influenced the overall tax burden. The net-of-tax presentation of interest paid implies tax benefits related to interest expense, but the fluctuating tax rate indicates these benefits were not constant.

The increasing interest expense, coupled with the fluctuating effective income tax rate, warrants further investigation into the company’s debt structure, financing activities, and tax planning strategies.

AI Ask an analyst for more


Enterprise Value to FCFF Ratio, Current

UnitedHealth Group Inc., current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 303,390
Free cash flow to the firm (FCFF) 19,585
Valuation Ratio
EV/FCFF 15.49
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories 23.73
Elevance Health Inc. 13.78
Intuitive Surgical Inc. 64.95
Medtronic PLC 22.50
EV/FCFF, Sector
Health Care Equipment & Services 21.05
EV/FCFF, Industry
Health Care 25.54

Based on: 10-K (reporting date: 2025-12-31).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.


Enterprise Value to FCFF Ratio, Historical

UnitedHealth Group Inc., historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 323,949 481,999 494,200 481,109 470,898
Free cash flow to the firm (FCFF)2 19,585 23,433 28,095 24,927 21,203
Valuation Ratio
EV/FCFF3 16.54 20.57 17.59 19.30 22.21
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories 25.54 35.21 36.51 23.24 23.47
Elevance Health Inc. 16.24 15.57 14.19 13.32 12.74
Intuitive Surgical Inc. 65.94 153.43 170.92 85.45 56.01
Medtronic PLC 22.40 20.58 26.54 20.32 33.84
EV/FCFF, Sector
Health Care Equipment & Services 22.24 25.57 22.68 20.44 23.51
EV/FCFF, Industry
Health Care 27.34 24.05 25.98 18.66 17.80

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 See details »

2 See details »

3 2025 Calculation
EV/FCFF = EV ÷ FCFF
= 323,949 ÷ 19,585 = 16.54

4 Click competitor name to see calculations.


The Enterprise Value to Free Cash Flow to the Firm (EV/FCFF) ratio exhibits a generally decreasing trend over the observed period, with some fluctuation. Enterprise Value remained relatively stable between 2021 and 2023, while Free Cash Flow to the Firm consistently increased during that timeframe. This combination resulted in a declining EV/FCFF ratio.

EV/FCFF Trend
The EV/FCFF ratio decreased from 22.21 in 2021 to 17.59 in 2023, indicating that the market value of the firm relative to its free cash flow generation was becoming more favorable. However, in 2024, the ratio increased to 20.57, potentially due to a decrease in FCFF or an increase in EV, or a combination of both. The ratio then decreased again in 2025 to 16.54, reaching its lowest point in the observed period.

Enterprise Value experienced a significant decrease in 2025, falling to 323,949 US$ in millions. This decrease, coupled with a continued, though smaller, decrease in Free Cash Flow to the Firm, contributed to the lowest EV/FCFF ratio recorded. The decrease in Enterprise Value in 2025 is a notable shift from the relative stability observed in the preceding years.

Free Cash Flow to the Firm (FCFF)
FCFF demonstrated consistent growth from 21,203 US$ in millions in 2021 to 28,095 US$ in millions in 2023. This positive trend suggests improving cash-generating capabilities. However, FCFF decreased in both 2024 and 2025, falling to 19,585 US$ in millions by the end of the period. This reversal in trend warrants further investigation.

The fluctuations in the EV/FCFF ratio suggest a dynamic relationship between the firm’s valuation and its cash flow generation. While the initial trend indicated increasing value relative to cash flow, the more recent data points suggest a potential shift in market perception or underlying business performance. The substantial decline in Enterprise Value in 2025 is a key factor driving the ratio’s final value.

AI Ask an analyst for more